Author:
Müller Arndt-Christian,Hölscher T.
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Abramowitz MC, Pollack A (2012) Hypofractionated radiotherapy for prostate cancer: has the time come? Oncology (Williston Park) 26:519, 522
2. Aluwini S, Pos F, Schimmel E et al (2015) Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial. Lancet Oncol 16:274–283
3. Arcangeli G, Fowler J, Gomellini S et al (2011) Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 79:1013–1021
4. Arcangeli S, Strigari L, Gomellini S et al (2012) Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 84:1172–1178
5. Bamberg M, Molls M, Sack H (2003) Radioonkologie. W. Zuckschwerdt, München